Media Database
>
Anthony Defino

Anthony Defino

Author at Healio at Healio

Contact this person
Email address
a*****@*******.comGet email address
Influence score
0
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    healio.com

    AURN001 yields positive BCVA, corneal thickness outcomes in phase 1/2 trial

    AURN001, an allogeneic cell therapy candidate, achieved positive results in a phase 1/2 clinical trial for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release from Aurion Biotech.
    healio.com

    VIDEO: AI may help build website, but customization needed

    In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, overview the advantages and disadvantages of using AI to build an ophthalmology practice website. Evans said that AI may be able to lay out a website to be more intuitive and offer advantages in cost. However, AI falls short when it comes to personalization and customization.
    healio.com

    Johnson & Johnson appoints Shawn Millerick as president of vision c...

    Shawn Millerick has been appointed as president of vision care, Americas, at Johnson & Johnson, according to a press release.“I am honored to step into the role of president, vision care, Americas, and lead our organization into its next phase of growth and innovation,” Millerick told Healio. “With a deep commitment to advancing patient care and outcomes, I will be
    healio.com

    VIDEO: Cataract surgery planning tools streamline lens calculations...

    NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, of Harvard Eye Associates discusses three tools to improve cataract surgery planning. The Veracity surgery planner from Zeiss, the SMARTCataract planner from Alcon and the Eyetelligence platform from Bausch + Lomb are designed to provide ophthalmologists a more streamlined and less error-prone way
    healio.com

    VIDEO: Access to biosimilars, on-label bevacizumab important for re...

    NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, of Cleveland Clinic Florida discusses the need for anti-VEGF biosimilars and the possibility of on-label bevacizumab. According to Singh, increased availability of anti-VEGF biosimilars will improve patient access and decrease cost of care. He also discussed the impact of the recent shortage of
    healio.com

    VIDEO: Technology needed to measure impact of geographic atrophy tr...

    NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, of Duke Eye Center in Durham, North Carolina, discusses the adoption of therapies for the treatment of geographic atrophy.“There is a big need for identifying technologies that will not only help us identify patients who will benefit but also see the effect of the therapy we are using,
    healio.com

    VIDEO: Tecnis Odyssey IOL provides balance of visual quality, range

    CHICAGO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, of Empire Eye and Laser Center discusses his Refractive Surgery Subspecialty Day presentation on the categories of presbyopia-correcting IOLs.
    healio.com

    VIDEO: Corneal endothelial cell therapy shows promise in improving ...

    CHICAGO — In this Healio Video Perspective from the AAO meeting, Matthew Giegengack, MD, of Wake Forest University discusses the outcomes of corneal endothelial cell therapy for endothelial dysfunction. The study’s benchmarks for measuring efficacy outcomes were best corrected visual acuity and brightness acuity testing.
    healio.com

    Oral treatment aims to reduce GA progression by slowing vitamin A d...

    CHICAGO — Decreasing vitamin A dimerization may be a promising treatment avenue for treating geographic atrophy, according to a speaker here.In his presentation at Retina Subspecialty Day at the American Academy of Ophthalmology meeting, Alexander Melamud, MD, unveiled topline results from the phase 3 SAGA study investigating the efficacy, safety and pharmacokinetics of oral gildeuretinol,
    healio.com

    VIDEO: Bausch + Lomb prepares for Teneo trial program for transEpi PRK

    CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anthony Wallace of Bausch + Lomb provides an update on the latest happenings at the company.
    healio.com

    VIDEO: Neurotech Pharmaceuticals offers macular telangiectasia educ...

    CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Richard Small, CEO of Neurotech Pharmaceuticals, provides a company update ahead of the American Academy of Ophthalmology Meeting.Neurotech submitted a biologics license application for its macular telangiectasia therapy, NT-501, to the FDA in April, Small said. As Healio previously reported, NT-501 was granted priority